A Machine Learning Approach for PLGA Nanoparticles in Antiviral Drug Delivery

Author:

Noorain Labiba1,Nguyen Vu2ORCID,Kim Hae-Won345,Nguyen Linh T. B.36ORCID

Affiliation:

1. Department of Pharmaceutics, School of Pharmacy, University College London, London WC1N 1AX, UK

2. Machine Learning Research Group, Eagle House, University of Oxford, Oxford OX2 6ED, UK

3. UCL Eastman-Korea Dental Medicine Innovation Centre, Dankook University, Cheonan 31116, Republic of Korea

4. Institute of Tissue Regeneration Engineering, Dankook University, Cheonan 31116, Republic of Korea

5. BK21 NBM Global Research Centre for Regenerative Medicine, Dankook University, Cheonan 31116, Republic of Korea

6. Eastman Dental Institute, University College London, Royal Free Hospital, Rowland Hill Street, London NW3 2PF, UK

Abstract

In recent years, nanoparticles have been highly investigated in the laboratory. However, only a few laboratory discoveries have been translated into clinical practice. These findings in the laboratory are limited by trial-and-error methods to determine the optimum formulation for successful drug delivery. A new paradigm is required to ease the translation of lab discoveries to clinical practice. Due to their previous success in antiviral activity, it is vital to accelerate the discovery of novel drugs to treat and manage viruses. Machine learning is a subfield of artificial intelligence and consists of computer algorithms which are improved through experience. It can generate predictions from data inputs via an algorithm which includes a method built from inputs and outputs. Combining nanotherapeutics and well-established machine-learning algorithms can simplify antiviral-drug development systems by automating the analysis. Other relationships in bio-pharmaceutical networks would eventually aid in reaching a complex goal very easily. From previous laboratory experiments, data can be extracted and input into machine learning algorithms to generate predictions. In this study, poly (lactic-co-glycolic acid) (PLGA) nanoparticles were investigated in antiviral drug delivery. Data was extracted from research articles on nanoparticle size, polydispersity index, drug loading capacity and encapsulation efficiency. The Gaussian Process, a form of machine learning algorithm, could be applied to this data to generate graphs with predictions of the datasets. The Gaussian Process is a probabilistic machine learning model which defines a prior over function. The mean and variance of the data can be calculated via matrix multiplications, leading to the formation of prediction graphs—the graphs generated in this study which could be used for the discovery of novel antiviral drugs. The drug load and encapsulation efficiency of a nanoparticle with a specific size can be predicted using these graphs. This could eliminate the trial-and-error discovery method and save laboratory time and ease efficiency.

Funder

UCL

Publisher

MDPI AG

Subject

Pharmaceutical Science

Reference31 articles.

1. Why 90% of clinical drug development fails and how to improve it?;Sun;Acta Pharm. Sin. B,2022

2. Hester, R.E., and Harrison, R.M. (2015). Pharmaceuticals in the Environment, The Royal Society of Chemistry.

3. Wong, H.H., Jessup, A., Sertkaya, A., Birkenbach, A., Berlind, A., and Eyraud, J. (2014). Examination of Clinical Trial Costs and Barriers for Drug Development Final.

4. Merging Data Curation and Machine Learning to Improve Nanomedicines;Chen;Adv. Drug Deliv. Rev.,2022

5. Machine learning in drug discovery: A review;Dara;Artif. Intell. Rev.,2022

Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3